Thursday, May 11, 2017 9:00:39 AM
BTX - 3.07/3.12
BioTime Reports Encouraging Data on Retinal Restoration Technology
The company said the technology could eventually be used to repair and restore sections of degenerated retinal tissue, and possibly help restore visual function, irrespective of the condition that caused vision loss or blindness.
The study's authors concluded that BioTime's 3-D retinal tissue may address the limiting factor of implementing a retinal restoration strategy to address severe retinal degenerative diseases.
BioTime Reports Encouraging Data on Retinal Restoration Technology
The company said the technology could eventually be used to repair and restore sections of degenerated retinal tissue, and possibly help restore visual function, irrespective of the condition that caused vision loss or blindness.
The study's authors concluded that BioTime's 3-D retinal tissue may address the limiting factor of implementing a retinal restoration strategy to address severe retinal degenerative diseases.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
